跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Diabutrate - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Diabutrate
Approved
STANDARD
Diabutrate
Orion Pharma Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c56222b1add6bd95
Company
Orion Pharma Ltd.
Type
Standard
Approval Details
Approval Id
c56222b1add6bd95
Drug Approval Philippines Name
Diabutrate
Product Name
Diabutrate
Registration Number
DRP-11108-01
Brand Name
Diabutrate
Generic Name
Butamirate Citrate
Dosage Form
Film-Coated Sustained-Release Tablet
Dosage Strength
50 mg
Manufacturer
Orion Pharma Ltd.
Importer
Ambica International Corporation
Distributor
Diafarm Inc
Issuance Date
27 May 2022
Expiry Date
03 February 2027
Pharmacologic Category
Antitussive
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c56222b1add6bd95
Type
Standard
Back to Philippines FDA Approvals